Historically, AD has been chiefly defined by its pathological signature, which includes β-amyloid deposits in the form of extracellular amyloid β (Aβ) plaques and hyperphosphorylated Tau aggregates in the form of intracellular neurofibrillary tangles (NFTs) [1]. Here, MAPT is linked to Alzheimer disease.